About Gus Tai
Form D filings for Cyrus Biotechnology from 2017 to 2021 list Gus Tai as director.
Gus Tai first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Gus Tai in the role, so the role may have started earlier or lasted longer.
Cyrus Biotechnology, Inc.
Director
2017 – 2021 · Seattle, WA
Develops protein-based drug candidates for its own pipeline and biotechnology and pharmaceutical partners.
Key Colleagues at Startups
The people Gus Tai works with at each company, as listed on that company's latest Form D.
Cyrus Biotechnology, Inc. · Form D/A, Dec 2, 2021
CW
Chad Waite
Board Member
Mark Benjamin
President and EVP Business Development
Yifan Song
Chief Technology Officer and director
Lucas Nivon
Chief Executive Officer and director